Press Release: Harvard Apparatus Regenerative Technology obtains orphan drug designation from U.S. FDA for HART-Trachea
Press Release
Press Release: REVIVE SE thrombectomy device approved for ischemic stroke patients in China, South Korea and Taiwan
Press Release: Stereotaxis receives FDA clearance of Vdrive with V-Loop system
Press Release: Abbott receives CE Mark for FreeStyle Libre, a revolutionary glucose monitoring system for people with diabetes
Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope
Roswell, Georgia – CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED’s) including pacemakers and implantable cardioverter defibrillators (ICD’s).
Press Release: Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems
FORT LAUDERDALE, Fla. – Nipro Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared its True Metrix Self-Monitoring blood glucose system and the True Metrix Pro Professional Monitoring blood glucose system.
Press Release: Medtronic Viva cardiac resynchronization therapy-pacemaker now available in U.S.
MINNEAPOLIS – Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P, for indicated patients with heart failure or atrioventricular (AV) block.
Press Release: Intuitive Surgical receives Firefly FDA clearance for da Vinci Xi surgical system
Press Release: AliveCor receives first FDA clearance to detect a serious heart condition in an ECG on a mobile device
Press Release: FDA approves donor lung preservation device that may result in more lung transplants
Press Release: FDA approves first non-invasive DNA screening test for colorectal cancer
The U.S. Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer.
